Home/Specialties/Urology
Urology Billing & RCM

Urology billing and revenue cycle, 50-state coverage.

Urology billing and revenue cycle services from ASP-RCM Solutions. 6,339 NPPES urology billing providers across all 50 states + DC. HIPAA + SOC 2 Type II compliant. Senior partners on every account.

Free urology billing audit → See 50-state coverage

What good urology billing execution looks like.

The operating discipline we install on every urology billing engagement.

  1. In-office procedure and pathology billing accuracyUrology generates significant in-office revenue from cystoscopy, biopsy, prostate procedures, and in-office pathology specimens. Urology practices need accurate procedure and 88305 pathology billing.
  2. Modifier 25 discipline for office visits + proceduresUrology visits routinely include procedures (cystoscopy, biopsy) the same day. Modifier 25 must be defensible with separate documentation supporting the E/M.
  3. Robotic surgery and OR coding for prostatectomy + nephrectomyRobotic urologic surgery (da Vinci prostatectomy, nephrectomy) carries distinct code stacks. Urology practices doing robotic surgery need coders who understand the procedural specifics.
  4. Prior authorization for advanced imaging and infusionUrology PA volume centers on MRI, CT, and immunotherapy infusion for advanced GU cancers. PA automation compresses cycle time materially.
  5. BPH treatment coding (Rezum, UroLift, etc.)Newer BPH treatments carry specific CPT codes with coverage and PA requirements that vary by state and payer. Coding accuracy and PA discipline are foundational.
  6. Specialty drug J-code billing for urologic cancersUrologic oncology drug billing follows the same ASP+6 logic as medical oncology. Accuracy is essential.

Procedure and pathology revenue map

Where a urology practice actually earns, component by component.

A urology visit is not one billable event. It is up to five of them, and each one is decided by a different person at a different moment. Three of those decisions happen inside your own building. The exhibit below is drawn from the coding rules and the federal timelines that govern them, not from sample data and not from a client.

Urology procedure and pathology revenue map ONE UROLOGY VISIT, THE FIVE BILLABLE COMPONENTS AND WHERE EACH IS DECIDED REVENUE COMPONENTWHAT DECIDES WHETHER IT PAYSIF IT IS DECIDED LATE OR WRONG In-office visit E/M billed the same day asa procedure The note has to carry a separatelyidentifiable evaluation before theprocedure is documented. Modifier 25is defended by the record. The E/M line denies, or it pays now andfails a post-payment audit later. In-office procedure cystoscopy, biopsy,urodynamic studies Site of service, and the professionalversus technical split on urodynamicstudies: who owns the equipment andwhose staff performed the study. The technical component is billed by apractice that does not own the equipment,or never billed by one that does. In-house pathology CPT 88305, level IVsurgical pathology Who grossed and read the specimen, andwho owns the laboratory. 88305 splitsinto a professional and a technicalcomponent. The specimen is billed globally when onlythe professional component was earned. Advanced imaging MRI, CT and PET forstaging and surveillance Prior authorization. From January 1, 2026impacted payers decide standard requestsin 7 calendar days and expedited requestsin 72 hours. The study is performed ahead of the answerand billed at risk. The appeal takes longerthan the imaging did. High-cost drug Part B, paid on theaverage sales price A different clock. Drugs are excluded fromthat rule. Medicare Advantage answersexpedited Part B drug requests in 24 hours,non-expedited in no more than 72 hours. Two clocks run at once on one patient. TheJ-code line is the one that goes unpaid whenonly one of them was started. Three of these five components are settled inside your own office before the claim exists.The other two are settled by a payer clock that only starts when somebody starts it.

Sources for the exhibit: CPT 88305 descriptor and the professional and technical component split, AMA Current Procedural Terminology with the CMS Medicare Physician Fee Schedule PC/TC indicator; prior authorization decision timeframes, CMS Interoperability and Prior Authorization final rule, 89 FR 8758, February 8, 2024; exclusion of drugs from that rule and the Medicare Advantage Part B drug timelines, 89 FR 8758 and 42 CFR 422.572 and 422.568.

The rules you are billing under

Six things a urology practice should know cold.

Each item below carries its source. We do not publish benchmarks we cannot point at.

6,339
Urology orgs in NPPES

Urology billing organizations registered across all 50 states and DC. ASP-RCM publishes a field guide for every one of them.

NPPES registry, ASP-RCM specialty universe build
88305
The in-house pathology code

Level IV surgical pathology, gross and microscopic examination, is where a routine prostate or bladder specimen lands. It splits into a professional and a technical component, so who read the slide and who owns the lab decides what you may bill.

AMA Current Procedural Terminology; CMS Medicare Physician Fee Schedule PC/TC indicator
7 calendar days
Standard prior authorization decision

From January 1, 2026 impacted payers must decide standard prior authorization requests within 7 calendar days and expedited requests within 72 hours. That covers Medicare Advantage, Medicaid and CHIP, and issuers of qualified health plans on the federally facilitated exchanges.

CMS Interoperability and Prior Authorization final rule, 89 FR 8758, February 8, 2024
24 hours
The drug clock runs separately

Drugs are excluded from that rule. Medicare Advantage plans answer expedited Part B drug requests within 24 hours and non-expedited requests in no more than 72 hours. A urology practice authorising imaging and a high-cost drug is running two different clocks on the same patient.

89 FR 8758, Exclusion of Drugs; 42 CFR 422.572 and 42 CFR 422.568
$33.5675
CY 2026 conversion factor

The qualifying-APM conversion factor for CY 2026. Clinicians not in a qualifying APM are paid on $33.4009. Every in-office cystoscopy, biopsy and urodynamic RVU passes through one of those two numbers.

CMS CY 2027 Physician Fee Schedule proposed rule impact analysis, 91 FR 43842
106%
How Part B drugs are paid

Most separately payable Part B drugs are paid at 106 percent of the average sales price. On urologic oncology drugs the margin is decided by acquisition discipline and by unit and waste accuracy on the J-code line, not by the fee schedule.

Social Security Act 1847A (42 U.S.C. 1395w-3a)

Revenue leakage taxonomy

The five places urology revenue actually leaks.

Urology denials are not random. They cluster into five drivers, and four of the five are settled by a decision made before the claim is ever submitted. This is the taxonomy we work against on every urology engagement.

Leakage driverHow the dollars go missingThe pre-bill control we installFixable pre-bill
In-office procedure and urodynamicsSite of service and the technical componentThe practice performs cystoscopy, biopsy and urodynamic studies in its own rooms, on its own equipment, with its own staff, and then bills them as though a facility or an outside provider owned part of the work. Urodynamic studies in particular split into professional and technical components, and several of them are commonly performed in one session.A standing rule per study type that fixes the professional and technical decision from who owns the equipment and whose staff performed the work, applied at charge entry rather than argued at appeal.Yes
In-house pathologyCPT 88305 and the PC/TC decisionThe practice runs its own laboratory but bills the specimen globally when an outside pathologist read the slide, or bills only the professional component when it owns the equipment and the technicians. Same specimen, wrong money, and the version auditors find is always the expensive one.Specimen accounting from accession to report, with the professional and technical split set by who grossed and read the specimen and who owns the laboratory, checked pre-bill on every 88305 line.Yes
Modifier 25 disciplineSame-day E/M plus procedureA single blended note covers both the evaluation and the cystoscopy, so the separately identifiable evaluation cannot be seen in the record. The claim either denies, or it pays and then fails a post-payment review years later with interest attached.Two distinct note sections, evaluation and procedure, with the evaluation element standing on its own before the procedure is documented, plus a pre-bill check on every modifier 25 line.Yes
Robotic surgery and the global packageBase code and post-operative periodThere is no CPT code that means robotic. A robot-assisted prostatectomy or nephrectomy is reported with the code for the operation actually performed, so the money is decided by base code accuracy and by whether concurrent work such as lymph node dissection was reported. Post-operative visits inside the global period then get billed as though the package did not exist.Operative note read against the base code before submission, with concurrent procedures identified explicitly, and global period tracking that flags every post-operative encounter before it becomes a claim.Yes
Prior authorization on imaging and drugsTwo clocks, one patientAdvanced imaging for staging and surveillance runs on the interoperability rule timelines from January 1, 2026, while the high-cost drug for the same patient runs on the separate drug timelines. Start one clock and not the other and the study is performed at risk or the J-code line goes unpaid.Both authorisations opened at the point the plan of care is set, tracked on their own clocks with their own escalation points, and a submission packet built to be decidable on the first read rather than on the third.Partly

The table describes ASP-RCM's operating taxonomy and the controls we install. It does not assert denial frequencies. Denial mix is measured per practice during the free 30-day audit against your own last 90 days of claim data. The prior authorization row reflects the decision timeframes finalised at 89 FR 8758 and the separate drug timelines at 42 CFR 422.572 and 422.568.

Money map

From visit booked to cash posted.

Five stages. Three leak points. Every leak sits upstream of the clearinghouse, which is why chasing urology denials after submission never gets a practice to a clean net collection rate. Our full treatment of the authorisation stage is in the prior authorization command center whitepaper.

Urology claim to cash money map 0102030405 Visit and procedureplanned together Evaluation loggedapart from procedure Authorizationsstarted, both clocks Coded: procedure,pathology, J-code Payment posted,cash collected LEAKLEAKLEAK One blended note, somodifier 25 cannot bedefended later Imaging or drug givenbefore the payer hasanswered on its clock Pathology split wrong,or drug units and wastenot reported All three leaks sit upstream of the clearinghouse. Working them after submission is appeals work.Working them before submission is revenue.

Top urology billing markets by NPPES org count.

State-level RCM guides for the largest urology billing markets in the U.S.

Florida697 orgs → California592 orgs → New York515 orgs → Texas344 orgs → North Carolina311 orgs → Pennsylvania309 orgs → Maryland248 orgs → Ohio220 orgs →

View all 50 state guides →

Urology billing FAQ

Questions urology practice owners actually ask.

How is in-house pathology billed in a urology practice?

CPT 88305 is level IV surgical pathology, gross and microscopic examination, and it is where a routine prostate or bladder specimen lands. Like an imaging study, it splits into a professional component and a technical component. If an outside pathologist read the slide, the practice cannot bill globally. If the practice owns the laboratory, the equipment and the technicians, the technical component belongs to it. That decision belongs at charge entry, driven by specimen accounting from accession to report, not at appeal after a payer has already made it for you.

What changes for urology prior authorization on January 1, 2026?

Impacted payers must decide standard prior authorization requests within 7 calendar days and expedited requests within 72 hours. The requirement comes from the CMS Interoperability and Prior Authorization final rule published at 89 FR 8758 on February 8, 2024, and it reaches Medicare Advantage organisations, state Medicaid and CHIP programmes and their managed care plans, and issuers of qualified health plans on the federally facilitated exchanges. For a urology practice the practical effect lands on advanced imaging for staging and surveillance, which is where most of the authorisation volume sits.

Do those deadlines apply to high-cost urology drugs?

No. That final rule explicitly excludes drugs from the prior authorization requirements, because the standards and processes for drug authorisations differ from those for medical items and services. Drugs run on their own timelines instead: a Medicare Advantage plan must answer an expedited request for a Part B drug within 24 hours and a non-expedited request in no more than 72 hours, under 42 CFR 422.572 and 42 CFR 422.568. A urology practice authorising an MRI and an immunotherapy drug for the same patient is therefore running two clocks with two rulebooks, and both have to be started deliberately.

Is there a separate CPT code for robotic urologic surgery?

No. CPT does not carry a code that means robotic. A robot-assisted radical prostatectomy or nephrectomy is reported with the code for the operation actually performed, and the use of the robotic system is documented in the operative note rather than coded as a service of its own. That puts the revenue on three things instead: accuracy of the base code, correct reporting of concurrent work such as a lymph node dissection, and clean tracking of the post-operative global period so that included visits are not billed and excluded visits are not written off.

Why do urodynamic studies get paid inconsistently?

Because a urodynamic session is rarely one code and rarely one billing decision. Several studies from the urodynamics family are commonly performed together, most of them carry a professional and a technical component, and payer rules on which combinations are payable in one session are not uniform. The practice that owns the equipment and staffs the study owns the technical component. The practice that sends the patient elsewhere does not. Setting that rule per study type at charge entry recovers more than appealing the same denial every month.

Free 30-day audit for urology billing providers.

Send us your last 90 days of claim data. We assess realization, denial patterns, and operational discipline. Written 4-page report yours to keep.

Request audit →Talk to a senior partner

Urology billing by state.

Dedicated Urology billing and credentialing field guides for 44 states. Each state guide opens into its city-level guides with local payer, Medicaid, and credentialing detail.